Ergotism associated with HIV antiviral protease inhibitor therapy.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 12618710.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Ergotism is a rare condition of acute vasospasm found classically in young and middle-aged women taking ergot alkaloid agents to treat migraine headache. We report the case of a young man with human immunodeficiency virus (HIV) positivity and describe the drug interaction between protease inhibitors and ergot alkaloid agents, which most likely predisposed to development of ergot toxicity. The HIV-positive population receiving antiviral therapy may be an under-recognized group at risk for ergotism through decreased hepatic metabolism of ergot preparations.
Medical subject headings
- Ergotamine
- Ergotism
- HIV Protease Inhibitors
- Vasoconstrictor Agents